Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Immunology of the Maternal-Fetal Interface
2013
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Breast cancer
2019 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
DNA methylation arrays as surrogate measures of cell mixture distribution
2012 Standout
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
2007
Uterine Artery Doppler Flow and Uteroplacental Vascular Pathology in Normal Pregnancies and Pregnancies Complicated by Pre-eclampsia and Small for Gestational Age Fetuses
2001
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta
2004
CD44: From adhesion molecules to signalling regulators
2003 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Endometriotic disease: the role of peritoneal fluid
1998
A Novel Three‐Dimensional In Vitro System to Study Trophoblast–Endothelium Cell Interactions
2007
Mitochondrial DNA mutations in human cancer
2006
Efficacy of 2-halogen substituted d-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”
2006
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Recent Insights into the Pathogenesis of Pre-eclampsia
2002
Ovarian cancer
2014 Standout
Inflammation and pregnancy: the role of the immune system at the implantation site
2011 Standout
HO in pregnancy
2005
Endometriosis
2009 Standout
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
Occult Metastases in Axillary Lymph Nodes as a Predictor of Survival in Node-Negative Breast Carcinoma with Long-term Follow-up
2004
Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: A report from the International Pleuropulmonary Blastoma Registry
2011
Head and neck cancer
2008 Standout
Apoptosis and its role in the trophoblast
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Immunobiology of endometriosis
2001
Macrophages and Apoptotic Cell Clearance During Pregnancy
2004
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion
2006
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
2008
Monocytes and Macrophages in Pregnancy and Pre-Eclampsia
2014
Elevated plasma endothelial microparticles in preeclampsia
2003
Pre-eclampsia
2005 Standout
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Human papillomaviruses and cancer
2013
Imbalance in Absolute Counts of T Lymphocyte Subsets in Patients with Head and Neck Cancer and Its Relation to Disease1
2004
M1/M2 Macrophage Polarity in Normal and Complicated Pregnancy
2014
The molecular pathology of breast cancer progression
2010
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
2011
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
FDG-PET for management of cervical and ovarian cancer
2005
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer
2011
DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma
2003
Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia
2003
Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension
2004
Pre-eclampsia
2010 Standout
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
2013
Clinical features and prognostic factors of early breast cancer at a major cancer center in North India
2005
Reactive oxygen species in cancer
2010 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
2010
Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors
2002
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
2008
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
2004
Pre-eclampsia, the Placenta and the Maternal Systemic Inflammatory Response—A Review
2003
Endometriosis
2004 Standout
The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
2006 Standout
The follow-up of ovarian cancer
2003
New modalities in detection of recurrent ovarian cancer
2004
Cervical cancer
2019 Standout
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
The 17q23 Amplicon and Breast Cancer
2003
The cancer genome
2009 StandoutNature
Macrophage-Induced Apoptosis Limits Endovascular Trophoblast Invasion in the Uterine Wall of Preeclamptic Women
2001
Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics
2004
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer
2017
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Evolution of the immune system in humans from infancy to old age
2015 Standout
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
2001
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and Neck
2004
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
The Role of Decidual Macrophages During Normal and Pathological Pregnancy
2016
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
2004
Seroepidemiological studies of human papilloma virus (HPV‐1) infections
1978 StandoutNobel
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of W. Schröder being referenced
GLUT1 mRNA and Protein Expression in Ovarian Borderline Tumors and Cancer
2004
The Distribution of Macrophages in Spiral Arteries of the Placental Bed in Pre-eclampsia Differs from that in Healthy Patients
1999
Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR
1998
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian Cancer
2001
GLUT1 Messenger RNA and Protein Induction Relates to the Malignant Transformation of Cervical Cancer
2003
Colour Doppler sonography improves the pre-operative diagnosis of ovarian tumours made using conventional transvaginal sonography
1996
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
2006
Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization
2001
Elevated soluble adhesion molecules in women with pre-eclampsia
1999
Long-term Follow-up and Prognostic Significance of Angiogenic Basic Fibroblast Growth Factor (bFGF) Expression in Patients with Breast Cancer
2002
Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor
2001
Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
1998
Interleukin-6 and soluble interleukin-6 receptor in peritoneal fluid and serum of patients with endometriosis.
1996
Lymphocyte subsets in patients with ovarian and breast cancer.
1997
GLUT1 Messenger RNA and Protein Induction Relates to the Malignant Transformation of Cervical Cancer
2003
Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
2000